Vasoactive Intestinal Peptide (Sendout)

General Information

Lab Name
Vasoactive Intestinal Peptide
Lab Code
RVIPEP
Epic Name
Vasoactive Intestinal Peptide
External Test Id
VIP
Description

Useful For: Detecting vasoactive intestinal polypeptide-producing tumors in patients with chronic diarrheal diseases.

Ordering Restrictions: This test should not be ordered on patients who have recently received radioactive material.

Synonyms
FVIP2, FVIPL, Vaso Polypeptide, VIP
Components

Interpretation

Method

Enzyme-Linked Immunosorbent Assay (ELISA)

Reference Range
Units: pg/mL
Female Male
AgeRange AgeRange
0-<86 0-<86

Effective date: 09/21/2024

Ref. Range Notes

Interpretation:

An elevated vasoactive intestinal polypeptide (VIP) may indicate the presence of an enteropancreatic tumor causing hypersecretion of VIP.

Vasoactive intestinal polypeptide-producing tumors are unlikely with a 24-hour stool volume below 700 mL.

Interferences and Limitations

Cautions:

Test results cannot be interpreted as absolute evidence for the presence or absence of malignant disease. Use vasoactive intestinal polypeptide (VIP) results in conjunction with information from the clinical evaluation of the patient and other diagnostic procedures. This test should not be used for cancer screening or cancer diagnosis.

Assay sensitivity may be lower than the previous VIP radioimmunoassay. The absence of elevated VIP does not rule out the presence of malignancy.

In rare cases, some individuals can develop antibodies to mouse or other animal antibodies (often referred to as human anti-mouse antibodies [HAMA] or heterophile antibodies), which may cause interference in some immunoassays. Caution should be used in interpretation of results and the laboratory should be alerted if the result does not correlate with the clinical presentation.

Vasoactive intestinal polypeptide concentration determinations are method dependent. Values obtained with different assay methods or kits may differ and cannot be used interchangeably.

Ordering & Collection

Specimen Type
Blood
Collection

3 mL blood in LAVENDER TOP (EDTA) tube

Note: Fasting samples are preferred. The patient should fast for 10 to 12 hours prior to collection of specimen.

Handling Instructions

Outside Laboratories: Promptly centrifuge sample and transfer plasma to a separate plastic vial. Freeze plasma immediately at -20°C while awaiting transport. Ship on dry ice.

Stability: Frozen: 90 days; Refrigerated: Unacceptable; Ambient: Unacceptable.

Unacceptable Conditions: Gross hemolysis or lipemia. Gross icterus: acceptable.

Quantity
Requested: 1 mL plasma
Minimum: 0.55 mL plasma

Processing

Receiving Instructions

Promptly centrifuge sample and transfer plasma to a separate plastic vial. Freeze plasma immediately at -20°C.

Sendouts:

  • Order Mayo Test: VIP
  • Interfaced: Yes [Interface: 601; Worksheet: MAFZ]

Stability: Frozen: 90 days; Refrigerated: Unacceptable; Ambient: Unacceptable.

Unacceptable Conditions: Gross hemolysis or lipemia. Gross icterus: acceptable.

Misc Sendout

Performance

Lab Department
Sendouts Mayo Lab (FZ)(MAFZ)
Frequency
Performed: Monday, Thursday. Report Available: 2-4 days from sample receipt at Mayo Clinic Laboratories.
Available STAT?
No
Performing Location(s)
Sendout Mayo Clinic Laboratories (Superior Drive)
800-533-1710

3050 Superior Drive NW
Rochester, MN 55901

Billing & Coding

CPT Codes
84586
LOINC
3125-2
Interfaced Order Code
UOW1963
Interfaced Result Code
UOW1963